Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-133 |
Sentence |
denotes |
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. |
T1 |
0-133 |
Sentence |
denotes |
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. |
TextSentencer_T2 |
134-254 |
Sentence |
denotes |
Neuroblastoma (NB) is a common pediatric tumor of neural crest origin that is biologically and clinically heterogeneous. |
T2 |
134-254 |
Sentence |
denotes |
Neuroblastoma (NB) is a common pediatric tumor of neural crest origin that is biologically and clinically heterogeneous. |
TextSentencer_T3 |
255-366 |
Sentence |
denotes |
EPH family receptor tyrosine kinases and ephrin ligands play fundamental roles in neurodevelopmental processes. |
T3 |
255-366 |
Sentence |
denotes |
EPH family receptor tyrosine kinases and ephrin ligands play fundamental roles in neurodevelopmental processes. |
TextSentencer_T4 |
367-531 |
Sentence |
denotes |
Recently, we found that NB cell lines expressed several EPHB and EFNB transcripts, which encode EPHB subgroup receptors and ephrin-B subgroup ligands, respectively. |
T4 |
367-531 |
Sentence |
denotes |
Recently, we found that NB cell lines expressed several EPHB and EFNB transcripts, which encode EPHB subgroup receptors and ephrin-B subgroup ligands, respectively. |
TextSentencer_T5 |
532-696 |
Sentence |
denotes |
To explore the role of EPHB receptors and ephrin-B ligands in the biology of NB, we examined the expression of EPHB and EFNB transcripts in 47 primary NB specimens. |
T5 |
532-696 |
Sentence |
denotes |
To explore the role of EPHB receptors and ephrin-B ligands in the biology of NB, we examined the expression of EPHB and EFNB transcripts in 47 primary NB specimens. |
TextSentencer_T6 |
697-873 |
Sentence |
denotes |
Multiple EPHB and EFNB transcripts were expressed in all of the NB tumors examined, suggesting the involvement of these transcripts in modulating the biological behavior of NB. |
T6 |
697-873 |
Sentence |
denotes |
Multiple EPHB and EFNB transcripts were expressed in all of the NB tumors examined, suggesting the involvement of these transcripts in modulating the biological behavior of NB. |
TextSentencer_T7 |
874-1077 |
Sentence |
denotes |
Higher levels of EPHB6, EFNB2, and EFNB3 expression were found in low-stage tumors (stage 1, 2, and 4S) than in advanced-stage tumors (stage 3 and 4; P = 0.0013, P = 0.0048, and P = 0.027, respectively). |
T7 |
874-1077 |
Sentence |
denotes |
Higher levels of EPHB6, EFNB2, and EFNB3 expression were found in low-stage tumors (stage 1, 2, and 4S) than in advanced-stage tumors (stage 3 and 4; P = 0.0013, P = 0.0048, and P = 0.027, respectively). |
TextSentencer_T8 |
1078-1273 |
Sentence |
denotes |
Expression of TrkA, a well-established prognostic marker of favorable NB, was positively correlated with EPHB6, EFNB2, and EFNB3 expression (P < 0.0001, P = 0.0019, and P = 0.0001, respectively). |
T8 |
1078-1273 |
Sentence |
denotes |
Expression of TrkA, a well-established prognostic marker of favorable NB, was positively correlated with EPHB6, EFNB2, and EFNB3 expression (P < 0.0001, P = 0.0019, and P = 0.0001, respectively). |
TextSentencer_T9 |
1274-1463 |
Sentence |
denotes |
MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively). |
T9 |
1274-1463 |
Sentence |
denotes |
MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively). |
TextSentencer_T10 |
1464-1671 |
Sentence |
denotes |
These data suggest that high-level expression of EPHB6, EFNB2, and EFNB3 is associated with favorable NB and that low-level expression of EPHB6, EFNB2, and EFNB3 correlates with aggressive MYCN-amplified NB. |
T10 |
1464-1671 |
Sentence |
denotes |
These data suggest that high-level expression of EPHB6, EFNB2, and EFNB3 is associated with favorable NB and that low-level expression of EPHB6, EFNB2, and EFNB3 correlates with aggressive MYCN-amplified NB. |
TextSentencer_T11 |
1672-1738 |
Sentence |
denotes |
Thus, EPHB6, EFNB2, and EFNB3 may have biological relevance in NB. |
T11 |
1672-1738 |
Sentence |
denotes |
Thus, EPHB6, EFNB2, and EFNB3 may have biological relevance in NB. |
TextSentencer_T12 |
1739-1841 |
Sentence |
denotes |
Further investigation on the biology of these genes may help provide insight into the treatment of NB. |
T12 |
1739-1841 |
Sentence |
denotes |
Further investigation on the biology of these genes may help provide insight into the treatment of NB. |